|
Powered by Cell Signaling Technology |
Site Information |
---|
SSLEPDStyFDLPQS SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 2063601 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on p73: | |
Effects of modification on biological processes: | |
Inhibit interaction with: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Lu H, et al. (2014) CK2 Phosphorylates and Inhibits TAp73 Tumor Suppressor Function to Promote Expression of Cancer Stem Cell Genes and Phenotype in Head and Neck Cancer. Neoplasia 16, 789-800
25379016 Curated Info |
|
Soond SM, et al. (2008) p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1. Cell Cycle 7, 1214-23
18418051 Curated Info |
|
Koida N, et al. (2008) Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. J Biol Chem 283, 8555-63
18174154 Curated Info |